Inflammation in CRC is thought to involve cross-talk between immune cells, pro-inflammatory mediators, chemokines, and cytokines that leads to the activation of certain pathways such as NF-κβ and the JAK-STAT pathway leading to tumor cell proliferation and growth [23]. Here, NFKB1 is linked to neoplasm.